Appraising cervical mucus: a new approach to evaluating contraceptives

References

• Guttmacher Institute. Contraceptive Use in the United States [Internet]. New York: Guttmacher Institute; 2014 [cited 2014 Aug 12]. Available from: http://www.guttmacher.org/pubs/fb_contr_use.pdf
   Google Scholar
• United Nations, Department of Economic and Social Affairs, Population Division. Trends in contraceptive use worldwide. 2015.
   Google Scholar
• Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol. 1999;181:1263–1269.
   PubMed Web of Science ®Google Scholar
• Moghissi KS, Syner FN, McBride LC. Contraceptive mechanism of microdose norethindrone. Obstet Gynecol. 1973;41:585–594.
   PubMed Web of Science ®Google Scholar
• Wright SW, Fotherby K, Fairweather F. Effect of daily small doses of Norgestrel on ovarian function. J Obstet Gynaecol Br Commonw. 1970;77:65–68.
   PubMedGoogle Scholar
• Kesserü-Koos E. Influence of various hormonal contraceptives on sperm migration in vivo. Fertil Steril. 1971;22:584–603.
   PubMed Web of Science ®Google Scholar
• Mears E, Vessey MP, Andolsek L, et al. Preliminary evaluation of four oral contraceptives containing only progestogens. Br Med J. 1969;2:730–734.
   PubMed Web of Science ®Google Scholar
• Gibor Y, Cohen MR, Scommegna A. Effect of continuous administration of small doses of chlormadinone acetate on the cervical mucus and postcoital test. Fertil Steril. 1969;20:572–580.
   PubMed Web of Science ®Google Scholar
• Martinez-Manautou J, Giner-Velasquez J, Cortes-Gallegos V, et al. Daily progestogen for contraception: a clinical study. Br Med J. 1967;2:730.
   PubMed Web of Science ®Google Scholar
• Petta CA, Faundes A, Dunson TR, et al. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus. Fertil Steril. 1998;69:252–257.
   PubMed Web of Science ®Google Scholar
• Natavio MF, Taylor D, Lewis RA, et al. Temporal changes in cervical mucus after insertion of the levonorgestrel-releasing intrauterine system. Contraception. 2013;87:426–431.
   PubMed Web of Science ®Google Scholar
• Dunson TR, Blumenthal PD, Alvarez F, et al. Timing of onset of contraceptive effectiveness in norplant implant users. Part I. Changes in cervical mucus. Fertil Steril. 1998;69:258–266.
   PubMed Web of Science ®Google Scholar
• Han L, Taub R, Jensen JT. Cervical mucus and contraception: what we know and what we don’t. Contraception. 2017;96:310–321.
   PubMed Web of Science ®Google Scholar
• Moghissi KS, Syner FN, Evans TN. A composite picture of the menstrual cycle. Am J Obstet Gynecol. 1972;114:405–418.
   PubMed Web of Science ®Google Scholar
• Wolf DP, Blasco L, Khan MA, et al. Human cervical mucus. IV. Viscoelasticity and sperm penetrability during the ovulatory menstrual cycle. Fertil Steril. 1978;30:163–169.
   PubMed Web of Science ®Google Scholar
• Lebech PE, Svendsen PA, Ostergaard E. The effects of small doses of megestrol acetate on the cervical mucus. Int J Fertil. 1970;15:65–76.
   PubMedGoogle Scholar
• Moghissi KS, Marks C. Effects of microdose norgestrel on endogenous gonadotropic and steroid hormones, cervical mucus properties, vaginal cytology, and endometrium. Fertil Steril. 1971;22:424–434.
   PubMed Web of Science ®Google Scholar
• Barbosa IC, Coutinho E, Hirsch C, et al. Temporal relationship between uniplant insertion and changes in cervical mucus. Contraception. 1996;54:213–217.
   PubMed Web of Science ®Google Scholar
• Jonsson B, Landgren B-M, Eneroth P. Effects of various iuds on the composition of cervical mucus. Contraception. 1991;43:447–458.
   PubMed Web of Science ®Google Scholar
• Abbvie. Lupron (leuprolide acetate for depot administration) prescribing information [Internet]. Food and Drug Administration; 2015 [cited 2015 Jan 25]. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019732s-040,020517s035lbl.pdf
   Google Scholar
• Torgrimson BN, Meendering JR, Kaplan PF, et al. Depot-medroxyprogesterone acetate and endothelial function before and after acute oral, vaginal, and transdermal estradiol treatment. Hypertension. 2011;57:819–824.
   PubMed Web of Science ®Google Scholar
• Stricker R, Eberhart R, Chevailler M-C, et al. Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Clin Chem Lab Med. 2006;44:883–887.
   PubMed Web of Science ®Google Scholar
• Soules MR, McLachlan RI, Ek M, et al. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle. J Clin Endocrinol Metab. 1989;69:804–812.
   PubMed Web of Science ®Google Scholar
• Usadi RS, Groll JM, Lessey BA, et al. Endometrial development and function in experimentally induced luteal phase deficiency. J Clin Endocrinol Metab. 2008;93:4058–4064.
   PubMed Web of Science ®Google Scholar
• Hull MG, Savage PE, Bromham DR, et al. The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle (“ovulation”) derived form treated and untreated conception cycles. Fertil Steril. 1982;37:355–360.
   PubMed Web of Science ®Google Scholar
• Israel R, Mishell Jr. DR, Stone SC, et al. Single luteal phase serum progesterone assay as an indicator of ovulation. Am J Obstet Gynecol. 1997;176:804–490–491.
   Web of Science ®Google Scholar
• Tavaniotou A, Smitz J, Bourgain C, et al. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update. 2000;6:139–148.
   PubMed Web of Science ®Google Scholar
• WHO. WHO laboratory manual for the examination and processing of human semen [Internet]. WHO. 2016 [cited 2016 Feb 11]. Available from: http://www.who.int/reproductivehealth/publications/infertility/9789241547789/en/
   Google Scholar
• Edelman AB, Cherala G, Blue SW, et al. Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing. Contraception. 2016;94:52–57.
   PubMed Web of Science ®Google Scholar
• Bogan RL, Hennebold JD, Jensen JT. Identification of the menstrual cycle-associated activities that modulate circulating lipid levels in premenopausal women. Fertil Steril. 2013;100:S332.
   Google Scholar
• Slayden OD, Nayak NR, Burton KA, et al. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. J Clin Endocrinol Metab. 2001;86:2668–2679.
   PubMed Web of Science ®Google Scholar
• Novartis Pharmaceuticals. Vivelle-Dot Full Prescribing Information [Internet]. 2014. [cited 2014 Nov 10]. Available from: https://www.pharma.us.novartis.com/product/pi/pdf/Vivelle_DOT.pdf
   Google Scholar
• Back DJ, Orme ML. Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet. 1990;18:472–484.
   PubMed Web of Science ®Google Scholar
• Cox HJ. The pre-coital use of mini-dosage progestagens. J Reprod Fertil Suppl. 1968;6:167–172.
   Google Scholar
• Mills RN, Katz DF. A flat capillary tube system for assessment of sperm movement in cervical mucus. Fertil Steril. 1978;29:43–47.
   PubMed Web of Science ®Google Scholar
• Makler A. A new method for evaluating cervical penetrability using daily aspirated and stored cervical mucus. Fertil Steril. 1976;27:533–540.
   PubMed Web of Science ®Google Scholar
• Ola B. Accuracy of sperm-cervical mucus penetration tests in evaluating sperm motility in semen: a systematic quantitative review. Hum Reprod. 2003;18:1037–1046.
   PubMed Web of Science ®Google Scholar
• Farhi J, Valentine A, Bahadur G, et al. In-vitro cervical mucus-sperm penetration tests and outcome of infertility treatments in couples with repeatedly negative post-coital tests. Hum Reprod Oxf Engl. 1995;10:85–90.
   PubMed Web of Science ®Google Scholar
• Eggert-Kruse W, Leinhos G, Gerhard I, et al. Prognostic value of in vitro sperm penetration into hormonally standardized human cervical mucus. Fertil Steril. 1989;51:317–323.
   PubMed Web of Science ®Google Scholar
• Eggert-Kruse W, Gerhard I, Tilgen W, et al. Clinical significance of crossed in vitro sperm-cervical mucus penetration test in infertility investigation. Fertil Steril. 1989;52:1032–1040.
   PubMed Web of Science ®Google Scholar